Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation risk.
Shih AW, Yan MTS, Elahie AL, Barty RL, Liu Y, Berardi P, Azzam M, Siddiqui R, Parvizian MK, Mcdougall T, Heddle NM, Al-Habsi KS, Goldman M, Cote J, Athale U, Verhovsek MM.
Shih AW, et al. Among authors: verhovsek mm.
Transfus Med. 2020 Aug;30(4):263-274. doi: 10.1111/tme.12685. Epub 2020 May 20.
Transfus Med. 2020.
PMID: 32432400